AFT Pharmaceuticals Limited (ASX:AFP) Annual Report 2021



The latest annual report of AFT Pharmaceuticals Limited (AFP) was published on 31 Mar 2021. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - AFP Annual Results

Amounts in NZD

Total Revenue
113.11M
Gross Profit
48.74M
EBIT
10.71M
Net Tangible Assets
21M
Net Income
7.78M
Capital Expenditures
-93k

AFP Income Statement 2021 Annual Report

As per the latest Income Statement of AFP, the Net revenue increased by $7.51M (7%) compared to the previous period. The operating income in 2021 decreased by $-794000 (-7%). The net income as per the annual report was 7.78M which decreased by $-4.91M (-39%) compared to previous year.

Income Statement Report (2021/2020)

20212020
Total Revenue113.11M105.6M
Gross Profit48.74M48.27M
Operating Income10.71M11.5M
Income Before Tax7.89M12.88M
Net Income7.78M12.69M

Balance Sheet - AFP 2021 Annual Report

Read further: AFP Balance Sheet Detailed Analysis

The latest balance sheet from annual result of AFT Pharmaceuticals Limited showed the company reduced the cash on balance sheet by $-2.91M (-48%). The Net tangible assets of AFP on the balance sheet were at 21M which is $30.00M (333%) more than previous annual report. The total stockholder equity also increased by $30.13M (466%) compared to previous reporting period.

Balance Sheet Statement Report (2021/2020)

20212020
Cash3.21M6.12M
Total Assets105.13M 87.05M
Long Term Debt33.2M41.2M
Total Liabilities68.54M 69.8M
Total Shareholder Equity36.59M6.46M
Net Tangible Assets21M-9M

Cash Flow Statement - AFP 2021 Annual Report

The 2021 annual cash flow statement of AFT Pharmaceuticals Limited showed that the net income decreased by $-4.91M (-39%) compared to previous reporting period. Also the capital expenditure of AFP decreased by $-1000 (-1%).

As of 2021, the total cash from investing activities was -6.23M and total cash from financing activities was 2.52M.

Cash Flow Statement Report (2021/2020)

20212020
Net Income7.78M12.69M
Capital Expenditures-93k-92k
Dividends Paid-188k-566k
Total Cash From From Investing Activities-6.23M-6.56M
Total Cash From From Financing Activities2.52M-9.12M

AFT Pharmaceuticals Limited Annual Report History

Income Statement

Income Statement history of AFT Pharmaceuticals Limited (ASX:AFP)

31 Mar 202131 Mar 202031 Mar 201931 Mar 2018
Total Revenue113.11M105.6M85.13M81.18M
Cost Of Revenue64.36M57.33M44.4M45.88M
Gross Profit48.74M48.27M40.73M35.3M
Research Development3.44M3.44M914k6.52M
Selling General Administrative35.22M37.3M35.42M38.55M
Non Recurring----
Other Operating Expenses-626k-535k-2.24M-1.13M
Total Operating Expenses102.4M94.09M78.49M89.82M
Operating Income10.71M11.5M6.64M-8.64M
Total Other Income Expense Net-2.82M1.38M-8.9M-4.02M
Ebit10.71M11.5M6.64M-8.64M
Interest Expense-3.44M-6.96M-5.39M-3.5M
Income Before Tax7.89M12.88M-2.26M-12.67M
Income Tax Expense105k185k168k58k
Minority Interest----
Net Income From Continuing Ops7.78M12.69M-2.43M-12.72M
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income7.78M12.69M-2.43M-12.72M
Net Income Applicable To Common Shares7.59M11.7M-3.36M-13.62M

Balance Sheet Statement

Balance Sheet Statement history of AFT Pharmaceuticals Limited (ASX:AFP)

31 Mar 202131 Mar 202031 Mar 201931 Mar 2018
Cash3.21M6.12M6.92M6.77M
Net Receivables29.23M22.63M16.28M14.78M
Inventory33.65M22.73M25.16M24.41M
Total Current Assets67.9M55.34M51.26M48.31M
Property Plant Equipment3.79M4.03M357k330k
Intangible Assets15.59M15.46M2.91M2.65M
Other Assets17.86M12.23M6.03M3.17M
Deferred Long Term Asset Charges724k705k705k708k
Total Assets105.13M87.05M63.59M56.6M
Accounts Payable14.7M8.62M6.67M7.33M
Short Long Term Debt5.16M2M41.75M-
Other Current Liab4M7.39M6.63M8.05M
Long Term Debt33.2M41.2M-30.65M
Deferred Long Term Liab17.13M11.52M5.33M2.46M
Total Current Liabilities32.1M25.1M58.5M18.61M
Total Liab68.54M69.8M58.5M49.26M
Common Stock80.36M57.06M57.06M57.06M
Retained Earnings-41.26M-49.27M-61.01M-57.64M
Treasury Stock-2.51M-1.32M-1.33M-1.68M
Other Stockholder Equity-2.51M-1.32M-1.33M-1.68M
Total Stockholder Equity36.59M6.46M-5.27M-2.27M
Net Tangible Assets21M-9M-8.19M-4.92M

Cash Flow Statement

Cash Flow Statement history of AFT Pharmaceuticals Limited (ASX:AFP)

31 Mar 202131 Mar 202031 Mar 201931 Mar 2018
Net Income7.78M12.69M-2.43M-12.72M
Depreciation975k956k243k241k
Change To Netincome3.5M82k7.85M3.34M
Change To Account Receivables-4.56M-7.3M-2.05M-1.08M
Change To Liabilities3.84M5.88M-1.88M3.17M
Change To Inventory-10.92M2.42M-746k-2.21M
Total Cash From Operating Activities750k14.88M1.07M-9.17M
Capital Expenditures-93k-92k-140k-70k
Total Cashflows From Investing Activities-6.23M-6.56M-4.88M-5.86M
Dividends Paid-188k-566k-134k-412k
Net Borrowings-5.49M-2.65M7.42M7.13M
Other Cashflows From Financing Activities-4.19M-5.9M-3.56M-1.93M
Total Cash From Financing Activities2.52M-9.12M3.72M5.86M
Effect Of Exchange Rate49k5k240k24k
Change In Cash-2.91M-797k146k-9.13M
Issuance Of Stock12.4M3k3k1.06M